RespiCare
Transcription
RespiCare
RespiCare Spiropraxy Chair ® ® The RespiCare® is a medical device that enables the practice of ventilatory exercises. It is conceived as a preventive health measure or as complement to a respiratory therapy intervention. The RespiCare® enables the performance of specific exercises that are beneficial to the ventilation development and increases the respiratory consciousness. The inability of the respiratory system to ensure a proper oxygenation of the tissues is often the cause of several lung diseases, as well as muscular, spinal or postural diseases. The RespiCare® is a prevention device for all these diseases. It is also a tool to reinforce the therapy actions in the field of the respiratory disorders and its consequences. The RespiCare® is available in two versions: • For an oxygen free use, or with the use of an external oxygen concentrator • With an integrated oxygen concentrator that provides 30% of oxygen. Oxygen and Breath of life Therapeutic Indications The RespiCare® provides support in the primary, secondary and tertiary preventions. In the Primary prevention, in patients at risk, the RespiCare® chair finds its place in the medical or paramedical environment before the illness or decompensation appears. The following fields are the most concerned by the primary prevention: • Stress and anxiety, the most frequent factors of inspiratory muscles spasms. • Smoking, as a complement of the cessation, to improve the management of the induced stress, and reinforce the cognitive-behavioural support which is critical for the success. • Obesity, complementing the changes in lifestyle and diet. • Aging, to promote the restoration of the thoracic spinal movement amplitude that decreases due to the age-related muscle atony. Regarding the Secondary prevention, the RespiCare® chair provides support to the treatments that prevent the aggravations of the disease through an active therapy optimization. Restrictive Lung Disease • Deficiency linked to the tidal volumes reduction • Pulmonary rehabilitation needs and recovery of the lost lung volume. • Interstitial lung disease, pulmonary fibrosis, drugs interactions in pneumopathy • Lobectomy after-effects, pneumonectomy (postoperative) • Kyphoscoliosis, obesity • Pleural sequelae, pneumothorax • Central neurological impairment, neuromuscular diseases Obstructive Lung Disease Inspiration • Deficiency related to the respiratory flow reduction • Deficiency in gas exchange (by insufficient tidal volumes) • Need to optimize by the optional supply of medical oxygen to reinforce the active therapy • Chronic obstructive pulmonary disease • Asthma • Emphysema Expiration In the Tertiary Prevention Upon recovery or stabilization, the RespiCare® chair holds a special place in the lung rehabilitation strategy. The aim is to prevent recurrence or relapse by reinforcing the respiratory capacity and by managing the stress and anxiety. This is achieved thanks to specific programs included in the settings of the RespiCare® chair. From the primary prevention, to providing support during the disease and reinforcing after the stabilization is achieved, the chair RespiCare® is an asset for any intervention in the area of the respiratory and related diseases. Innovation and Technology The objective of the RespiCare® chair is to restore and increase the depth of respiration of the subject in order to increase the lung capacity, thus enabling the gas exchange of the physiological breathing. The active system of the RespiCare® chair impulses progressive thrusts at the spine level. The rhythm of the thrusts and of its pressure is adjustable depending on the objectives and desired progressivity. The person is installed in a sitting position -reverse trendelenburg- with the weight evenly distributed, allowing a good hemodynamic and being effortless for the heart. Ventilatory cycle involvement in the respiratory physiomechanical area: vertebrae L3 to T10. End of cycle, maximum thoracic amplitude. Complementing the mechanical action, a pre-programmed software that can be adjusted by the practitioner, accompanies vocally and with music the rhythm of the thrusts. The biomechanical effect of the RespiCare® promotes the contraction of the external intercostals muscles, increasing the volume of the rib cage by lowering the diaphragm. The natural descent of the viscera amplifies the volume of the thoracic cage and increases the inspiratory volume. This increase in tidal volume enables a greater respiratory gas exchange. A regular training in the RespiCare® significantly enhances the lung capacity. For patients requiring oxygen supply, the exercises can be provided with the implementation of medical oxygen. Thrusts zone The RespiCare® can be used concurrently with a medical oxygen supplementation. If the oxygen source is a portable or fixed concentrator, it can be placed next to the RespiCare® and be used as usual following the medical prescription. It enables a greater gas exchange in the pulmonary alveoli. SCALEO® Medical offers a range of portable and stationary concentrators of up to 5 liters in continuous flow. SCALEO® Stationary concentrator of 5L in continuous flow and 14.4 Kgs. Portable concentrators Inogen® G2 and G3 - the quietest and smallest of the market. Inogen® Stationary concentrator of 5L in continuous flow and only 8.3 Kgs. Technical Features RespiCare® RespiCare® O2 inside Weight 104 kg 111 kg Electrical compatibility 220/110 V - Adapted plug Dimension 1250 x 800 x 1150 (lxwxh) Dimension active position 1800 x 800 x 950 (lxwxh) Oxygen External medical O2 concentrator Integrated concentrator Scaleo® Medical Oxygen and Breath of life 107 Dassin street, Parc 2000 - 34080 Montpellier Ph: +33 (0)4 67 72 94 86 - Fax : +33 (0)4 99 74 01 79 www.scaleomedical.fr - info@scaleomedical.com Ref. DO MA682 May 1st, 2016- Non contractual document. The manufacturer reserves the right to improve the characteristics and/or features of the presented products. Using RespiCare® with oxygen